GIRFT has produced a guide to support clinical teams in establishing diabetes safety boards.
This follows a recommendation in GIRFT’s national specialty report on diabetes, published in November 2020, which advised that a trust-level diabetes safety board attended by multidisciplinary clinical teams would reduce complications for inpatients with diabetes.
Vertex presented updated data from the Phase 1/2 portion of the Phase 1/2/3 FORWARD-101 clinical trial of zimislecel during the American Diabetes Association 85th Scientific Sessions.
The clinical trial analysed how people with type 1 diabetes with impaired hypoglycaemic awareness and severe hypoglycaemic events can benefit from zimislecel – an investigational stem cell-derived, fully differentiated islet cell therapy.
A world leading expert in diabetes has been recognised for her remarkable contribution to the prevention and treatment of the condition at a ceremony in the USA.
Professor Melanie Davies CBE received a 2025 National Scientific and Health Care Achievement Award at the American Diabetes Association (ADA)’s 85th Scientific Sessions conference in Chicago.
People with a history of foot ulcers or amputations should be prescribed SGLT2 inhibitors, according to new research led by a team from Leicester.
Professor Kamlesh Khunti, Dr Patrick Highton and a team of experts have identified a general clinical confidence in prescribing SGLT2 inhibitors to people with diabetes-related foot disease, so long as they do not have an active ulcer and the drug canagliflozin is not prescribed.
An inhaled form of rapid-acting insulin is a safe and effective alternative to injected insulin for children and adolescents with diabetes, according to study results presented at the American Diabetes Association’s 85th Scientific Sessions.
The INHALE-1 trial found that technosphere insulin was noninferior to rapid-acting analog insulin in managing HbA1c levels, and participants who used technosphere insulin experienced less weight gain and higher satisfaction with treatment.
NHS leaders in England can sign up for an ongoing leadership programme designed to improve the care of people with long-term conditions. To read more, click here.
Novo Nordisk presented the results from the phase 3b STEP UP trial for weight management in adults with obesity without diabetes at the ADA meeting. To read more, click here.
The government published its 10 Year Health Plan, setting out its ambition to rebuild the NHS and bring care closer to home.
It has committed to shift from hospital to community; analogue to digital; and sickness to prevention, as well as tackling the challenges set out in the Independent Review of the NHS last year.
A device has helped transform the life of a stroke survivor who was left dependent on nurses for daily insulin injections. To read more, click here.
Breakthrough T1D has partnered with Barbie to create the world’s first Barbie doll with type 1 diabetes. To read more, click here.
It always gives you a certain amount of fondness to see any of your children grow and flourish. And in the context of work, they would always be projects that have started off on a wish and a prayer. And yet close to a decade later, it still brings the feeling of joy and happiness as the first event of Talking About Diabetes did back in 2016. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Diabetes Practitioner – Hampshire and Isle of Wight Healthcare NHS Foundation Trust
Specialist Paediatric Diabetes Dietitian – East Suffolk and North Essex NHS Foundation Trust
Senior Diabetes Specialist Podiatrist – Sussex Community NHS Foundation Trust
Consultant in General Medicine, Diabetes and Endocrinology – Countess of Chester Hospital NHS Foundation Trust
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
